HGH 176-191 Peptide

HGH 176-191 Peptideyog ib qho 16-amino acid fragment sib thooj rau residues 176-191 ntawm C-terminus ntawm human growth hormone (hGH), tseem hu ua "lipolytic fragment." Nws nthuav tawm cov rog loj heev- txhawb nqa thiab kev sib txuas rog - inhibiting teebmeem, tsis muaj kev loj hlob - txhawb nqa lossis cov piam thaj metabolism- cuam tshuam cov kev mob tshwm sim cuam tshuam nrog tag nrho -ntev hGH. Tam sim no, nws yog siv feem ntau hauv kev tshawb fawb txog kev rog thiab metabolism. Tsim los ntawm 16 amino acids los ntawm C-terminus ntawm hGH, nws cov kab ke yog Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly{-}Ser{26} nrog rau qhov hnyav molecular ntawm kwv yees li 1817.1 g / mol thiab cov mis molecular ntawm C₇₈H₁₂₅N₂₃O₂₃S₂. HGH Fragment 176-191 Peptide (tom qab no hu ua peptide 176-191) ua rau pom muaj ntau yam teebmeem lom neeg hauv thaj chaw ntawm kev tswj cov pob txha metabolism, kho pob txha pob txha, thiab kev tiv thaiv kev sib koom tes. Nws cov haujlwm tseem ceeb hloov pauv ntawm kev tswj cov pob txha kho qhov sib npaug, tiv thaiv chondrocyte homeostasis, tswj cov synthesis-degradation tshuav nyiaj li cas ntawm pob txha mos matrix, thiab kho qhov sib koom ua ke microenvironment. Ntxiv mus, nws cov txheej txheem ntawm kev txiav txim yog tus yam ntxwv ntawm cov ntaub so ntswg tshwj xeeb thiab physiological maj mam.

 

Peb cov khoom nthuav dav

 

​

HGH 176-191 COA

Lub hauv paus ntawm cov pob txha metabolism yog nyob rau hauv qhov sib npaug ntawm osteoblast-kev tsim cov pob txha nruab nrab thiab osteoclast- kho pob txha resorption. Peptide 176-191 tuaj yeem ua kom zoo dua qub ntawm cov pob txha hloov kho thiab txhim kho cov txheej txheem thiab kev ua haujlwm ruaj khov ntawm cov pob txha los ntawm kev tswj cov haujlwm ntawm ob hom ntawm tes:

Txhawb nqa Osteoblast Proliferation thiab Functional Activation

Kev sim hauv vitro cell tau lees paub tias peptide 176-191 tuaj yeem ua ncaj qha rau osteoblast precursor hlwb, ua kom lawv sib txawv rau hauv cov pob txha loj.
Nws txhawb txoj kev qhia ntawm cov cim ua haujlwm tseem ceeb hauv osteoblasts-xws li osteocalcin, hom I collagen, thiab alkaline phosphatase- uas yog cov khoom tseem ceeb rau cov pob txha matrix synthesis thiab mineralization.

Cov peptide no tuaj yeem ua kom muaj kev cuam tshuam cov teeb meem hauv osteoblasts, txhim kho lawv lub peev xwm los tsim cov pob txha pob txha, yog li ncaj qha boosting efficiency ntawm pob txha matrix synthesis thiab mineralization, thiab pab cov pob txha siv thiab kho.

Nruab Nrab Inhibiting Osteoclast Activity kom txo cov pob txha ntau heev resorption

Kev ua kom osteoclast ntau dhau yog qhov ua rau lub hauv paus ua rau cov pob txha tsis zoo thiab ua rau cov pob txha microarchitecture deterioration. Peptide 176-191 tuaj yeem tswj hwm osteoclast sib txawv cov cim, inhibiting kev hloov ntawm osteoclast precursors mus rau cov laus osteoclasts.
Nws kuj tseem txo cov pob txha-resorbing muaj nuj nqi ntawm cov laus osteoclasts (xws li, lawv muaj peev xwm tsim cov pits resorption).

Nws cov nyhuv inhibitory yog physiologically nruab nrab; Nws tsis cuam tshuam rau cov txheej txheem physiological ntawm cov pob txha resorption tab sis tsuas yog kho qhov txawv txav qhov siab resorption.Qhov no yuav pab tswj lub cev nqaij daim tawv "pob txha tsim - pob txha resorption" sib npaug, txo cov pob txha txawv txav, thiab txhim kho pob txha ceev thiab kev ncaj ncees ntawm cov pob txha trabecular.

Optimizing Pob Txha Microenvironment los pab pob txha kho

Cov peptide no tuaj yeem hloov kho qhov tso tawm ntawm cov cytokines hauv zos hauv cov ntaub so ntswg, txhawb kev maj mam nthuav qhia txog kev loj hlob yam cuam tshuam txog kev kho pob txha.
Nws txhim kho cov khoom noj khoom haus thiab cell ciaj sia microenvironment ntawm cov pob txha. Tshwj xeeb hauv cov xwm txheej ntawm pob txha raug mob lossis micro- kho pob txha.

Nws tuaj yeem ua kom cov neeg ua haujlwm ntawm osteoblasts mus rau qhov chaw puas thiab tso cov pob txha matrix.Qhov no ua rau lub voj voog kho pob txha thiab txhim kho cov neeg kho tshuab lub zog ntawm cov pob txha kho.

 

 

Txhawb nqa Synthesis ntawm Chondrocyte Extracellular Matrix thiab kho pob txha mos Structure

Lub elasticity thiab compressive kuj ntawm articular pob txha mos nyob ntawm seb muaj pes tsawg leeg ntawm hom II collagen thiab proteoglycans. Peptide 176-191 tuaj yeem ua haujlwm ncaj qha rau matrix-synthesizing muaj nuj nqi ntawm chondrocytes.
Ntawm ib sab, nws upregulates cov noob qhia thiab protein synthesis ntawm hom II collagen thiab aggrecan, ua rau cov ntsiab lus ntawm cov pob txha mos matrix Cheebtsam.Ntawm qhov tod tes, nws txhawb cov synthesis thiab deposition ntawm glycosaminoglycans (GAGs) nyob rau hauv lub matrix, txhim khu lub hydration peev thiab txhua yam khoom ntawm pob txha mos. Qhov no thim rov qab degenerative poob ntawm pob txha mos matrix thiab kho nws cov microstructure.

Inhibiting the Activity of Cartilage Matrix-Degrading Enzymes thiab Blocking Cartilage Destruction

Matrix metalloproteinases (MMPs, piv txwv li, MMP-1, MMP-3, MMP-13) thiab ib qho disintegrin thiab metalloproteinase nrog thrombospondin motifs (ADAMTS, eg, ADAMTS-4, ADAMTS-5) yog cov enzymes tseem ceeb uas degrade. Lawv qhov kev qhia siab txawv txav yog lub hauv paus tsav tsheb ntawm pob txha mos degeneration.Peptide 176-191 tuaj yeem txo qis kev qhia thiab kev ua haujlwm ntawm cov enzymes degrading no, txo cov enzymatic tawg ntawm hom II collagen thiab proteoglycans.By thaiv qhov "degradation kawg," nws cuam tshuam qhov kev puas tsuaj tas mus li rau pob txha mos. Ua ke nrog nws cov kev txhawb nqa ntawm matrix synthesis, qhov no tsim ib qho kev cai "synthesis-degradation" bidirectional, ua tiav kev kho cov pob txha mos.

Raws li cov kev cai hais saum toj no rau cov pob txha thiab pob txha mos, peptide 176-191 qhia tau hais tias muaj peev xwm cuam tshuam tus nqi hauv ntau yam kev sib koom ua ke nrog cov xwm txheej, nrog rau kev tsom mus rau cov kab mob cuam tshuam nrog pob txha mos degeneration thiab kev puas tsuaj ntawm cov pob txha:

Muaj peev xwm cuam tshuam hauv Osteoarthritis (OA)

 

Osteoarthritis yog tus cwj pwm los ntawm kev loj hlob ntawm cov pob txha pob txha pob txha, kev tsim osteophyte, thiab cov kab mob synovial.
Cov kev tshawb fawb tsiaj pom tau hais tias kev cuam tshuam nrog peptide 176-191 tuaj yeem txo qhov hnyav ntawm pob txha pob txha puas hauv OA qauv. Nws txo qis pob txha pob txha pob txha, fibrosis, thiab matrix poob, thaum tswj cov pob txha mos tuab thiab kev ncaj ncees.Ib zaug, nws inhibits qhov txawv txav osteophyte proliferation, txo qis synovial o cov qhab nia, txhim kho kev sib koom ua haujlwm thiab ntau yam ntawm cov lus tsa suab, thiab qeeb OA pathological kev loj hlob.

Pab Kho Kho Cov Kabmob Pob Txha Pob Txha

 

Rau focal articular pob txha mos defects tshwm sim los ntawm kev raug mob los yog degeneration, peptide 176-191 tuaj yeem txhawb kev nrhiav neeg ua haujlwm thiab kev loj hlob ntawm chondrocytes nyob rau hauv qhov chaw tsis xws luag.
Qhov no ua rau cov pob txha mos hyaline nce ntxiv thiab txhim kho cov khoom siv kho tshuab ntawm cov pob txha mos, pab txhim kho kev ua haujlwm ntawm cov pob txha mos thiab txo qhov kev pheej hmoo ntawm kev loj hlob mus rau tag nrho - pob txha mos puas.

Peptide 176-191 qhov kev ua haujlwm hauv cov pob txha thiab cov pob qij txha muaj qhov zoo sib xws, qhov txawv ntawm qhov ntev-ntev loj hlob hormone thiab qee cov pob txha muaj zog metabolism modulators:

Physiological Gentleness

 

Nws cov kev cai ntawm cov pob txha tsim thiab pob txha pob txha synthesis koom nrog kev ua kom lub cev, tsis muaj kev cuam tshuam ntau dhau.
Nws tsis ua rau muaj kev hloov pauv pathological xws li cov pob txha txawv txav hyperplasia lossis cov pob txha mos ntau dhau. Nws feem ntau kho cov pob txha txawv txav thiab pob txha mos metabolic tsis txaus, rov ua kom lub cev homeostasis.

Lub cev Targeting:
Nws cov teebmeem yog tsom rau cov pob txha hlwb, chondrocytes, thiab kev sib koom ua ke microenvironment.
Nws tsis muaj kev cuam tshuam ncaj qha rau lwm cov ntaub so ntswg thiab cov khoom nruab nrog cev thoob plaws hauv lub cev, zam kev ua haujlwm tsis zoo ntawm cov ntaub so ntswg uas tsis yog - cov hom phiaj thiab ua kom muaj kev ua haujlwm siab.

Tsis tshua muaj kev phom sij

 

Nws tsis khi rau txoj kev loj hlob hormone receptor, tshem tawm kev txhawj xeeb nrog rau tag nrho -length growth hormone, xws li tej zaum cov teeb meem ntawm cov pob txha loj hlob los yog txawv txav sib koom ua ke.
Qhov no qhia txog qhov muaj peev xwm muaj peev xwm ntau dua rau kev cuam tshuam rau kev kho pob txha thiab pob txha.

Tam sim no, kev tshawb fawb ntawm peptide 176-191 hauv thaj chaw ntawm cov pob txha metabolism thiab kho pob txha pob txha feem ntau tseem nyob rau theem ntawm * hauv vitro * kev sim ntawm tes thiab cov qauv kab mob tsiaj. Cov kev tshawb pom tseem ceeb yog tsom mus rau nws lub luag haujlwm hauv kev tswj cov pob txha kho qhov sib npaug, tiv thaiv chondrocytes thiab extracellular matrix, thiab ncua kev sib koom ua ke degeneration. Txawm li cas los xij, los ntawm nws cov kev cai bidirectional thiab sib npaug ntawm cov pob txha metabolism, kev kho kom zoo nkauj thiab kev tiv thaiv rau pob txha mos pob txha, thiab kev ua kom zoo ntawm kev sib koom ua ke ntawm microenvironment, nws pom tau tias muaj txiaj ntsig tseem ceeb hauv cov xwm txheej xws li cov pob txha metabolic, pob txha pob txha degeneration, thiab kev kho mob pob txha. Nws txoj kev ua siab mos thiab meej meej muaj cov kev taw qhia tshiab rau kev tshawb fawb txog kev sib koom ua ke ntawm cov kab mob pob txha thiab kev tshawb nrhiav cov tswv yim cuam tshuam.

Cim npe nrov: HGH 176-191 Peptide, Tuam Tshoj HGH 176-191 Peptide manufacturers, lwm tus neeg